Skip to content

Minimally Invasive Non Surgical Treatment Using Injectable Platelet Concentrate in Treatment of Deep Pockets.

The Effect of Adjunctive I-PRF on the Outcomes of Minimally-invasive Non-surgical Therapy of Periodontal Intrabony Defects.A Randomized Clinical Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07722390
Enrollment
48
Registered
2026-07-23
Start date
2025-05-14
Completion date
2028-06-01
Last updated
2026-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrabony Periodontal Defects

Keywords

intrabony defect - MINST - IPR-F

Brief summary

The purpose of this study is to evaluate change in pocket depth following using minimally invasive non surgical combined with injectable platelet concentrate .

Interventions

BIOLOGICALInjectable PRF

I-PRF will be prepared from 10 mL of autologous venous blood and injected into the cleaned defect, followed by placement of a custom-made transparent vacuum-formed stent for 15 minutes to prolong local contact

PROCEDUREMINST

Participants will receive minimally invasive non-surgical periodontal therapy (MINST) alone using P3 Woodpecker piezoelectric scaler for the selected periodontal intrabony defect

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Biostatistician

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Patients with periodontitis stage III-IV. * Presence of at least one intrabony defect with radiographic component ≥ 3mm deep and PPD≥ 6mm (not affecting a tooth with 'hopeless' prognosis). * Patients willing to sign informed consent and to be in the study until the 6-months follow-up. * Full-mouth plaque score \<30% following step 1 periodontal therapy

Exclusion criteria

* Smoker/vaper (currently or in past 5 years). * Contributory medical history (e.g. cardiovascular disease, diabetes, psychiatric conditions).

Design outcomes

Primary

MeasureTime frameDescription
Change in pocket depth6 monthsBaseline measurements will be taken at the first visit. Probing depth will be measured at six sites per tooth (mesiobuccal, midbuccal, distobuccal, mesiolingual, midlingual, distolingual) using a UNC-15 periodontal probe

Secondary

MeasureTime frameDescription
Pocket closure6 months from baselinePocket depth of less than or equal 4 millimeters with no bleeding on probing at 6-month follow-up. PD will be measured from the gingival margin to the base of the pocket at six sites per tooth using a UNC-15 periodontal probe. PD reduction will be calculated by subtracting the 6-month PD from baseline PD
Clinical attachment gain6 months from baselineCAL will be measured from the cementoenamel junction (CEJ) to the base of the pocket at the same six sites using a UNC-15 periodontal probe. CAL gain will be calculated by subtracting follow-up CAL (6 months) from baseline CAL
Radiographic defect reduction:6 monthsPeriapical radiographs of selected study sites will be taken at baseline and at 6 months using the parallel technique with Rinn holders. Each participating practice used the same setting and exposure time for radiographs taken at both visits to standardize positioning and minimize distortion of sequential radiographs
Patient reported outcomes6 monthsTo evaluate patient perceptions about the performed procedure and post-therapy period. The extent of discomfort and/or pain experienced will be evaluated using a horizontal visual analog scale (VAS) measured from scale from 1 to 10 where 1 is the lowest \& 10 is the highest.

Countries

Egypt

Contacts

CONTACTHania Haggag
hania.haggag@dentistry.cu.edu.eg+01210239417

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 30, 2026